PROVIDER PROFILE · NPI 1326131699

Babatunde Adetunji

NeuropsychiatryPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

374

Beneficiaries

—

Total drug cost

$81K

Distinct drugs

Brand share

13.9%

Top prescribed drugs

Clonazepam80 claims

Gabapentin54 claims

Clozapine34 claims

Bupropion Hcl28 claims

Fluoxetine Hcl22 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Babatunde Adetunji's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
FRIENDS BEHAVIORAL HEALTH SYSTEM, LP	18	22

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Gretchen Magnani Psychiatry · Camden, NJ	16	41

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history